Skip to main content

Table 2 Echocardiographic structural data

From: Influence of apocynin on cardiac remodeling in rats with streptozotocin-induced diabetes mellitus

  CTL
(n = 13)
CTL + APO
(n = 19)
DM
(n = 17)
DM + APO
(n = 16)
LVDD (mm) 8.39 ± 0.62 8.24 ± 0.49 8.03 ± 0.51 7.82 ± 0.65#
LVSD (mm) 3.92 ± 0.48 3.87 ± 0.62 4.11 ± 0.62 4.16 ± 0.58
LVDD/BW (mm/kg) 15.6 ± 2.15 16.0 ± 1.74 25.7 ± 2.87* 25.3 ± 3.13#
PWT (mm) 1.47 ± 0.07 1.47 ± 0.07 1.37 ± 0.08* 1.32 ± 0.08#
LA (mm) 5.76 ± 0.95 5.92 ± 0.63 5.68 ± 0.77 5.35 ± 0.81#
LA/BW (mm/kg) 10.8 ± 2.35 11.6 ± 1.91 18.1 ± 2.35* 17.3 ± 3.03#
LVM/BW (g/kg) 1.68 ± 0.27 1.71 ± 0.26 2.44 ± 0.32* 2.25 ± 0.32#
  1. Data are expressed as mean ± standard deviation
  2. CTL control, CTL + APO control treated with apocynin, DM diabetes mellitus, DM + APO diabetes mellitus treated with apocynin, LVDD and LVSD left ventricular (LV) diastolic and systolic diameters, respectively, BW body weight, PWT LV posterior wall thickness, LA left atrial diameter, LVM LV mass
  3. * p < 0.05 vs CTL; # p < 0.05 vs CTL + APO